{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T04:53:14Z","timestamp":1774327994967,"version":"3.50.1"},"reference-count":27,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.3892\/mmr.2015.4103","type":"journal-article","created":{"date-parts":[[2015,7,20]],"date-time":"2015-07-20T08:39:13Z","timestamp":1437381553000},"page":"5594-5600","source":"Crossref","is-referenced-by-count":7,"title":["Human recombinant endostatin Endostar attenuates hepatic sinusoidal endothelial cell capillarization in CCl4-induced fibrosis in mice"],"prefix":"10.3892","volume":"12","author":[{"given":"QI","family":"YOU","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LING-JIAN","family":"KONG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FENG-DONG","family":"LI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HANG-YU","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DIAN-GANG","family":"LIU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FENG-HUA","family":"PEI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JI-TAO","family":"SONG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JUN","family":"XU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JING","family":"CHEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2015,7,20]]},"reference":[{"key":"key20180108021211_b1-mmr-12-04-5594","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-5926-1-1","article-title":"Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: A review","volume":"1","author":"Braet","year":"2002","journal-title":"Comp Hepatol"},{"key":"key20180108021211_b2-mmr-12-04-5594","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jhep.2007.02.006","article-title":"Vascular endothelial dysfunction in cirrhosis","volume":"46","author":"Iwakiri","year":"2007","journal-title":"J Hepatol"},{"key":"key20180108021211_b3-mmr-12-04-5594","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/hep.22351","article-title":"Sinusoidal endothelial cells prevent rat stellate cell activation and promote reversion to quiescence","volume":"48","author":"Deleve","year":"2008","journal-title":"Hepatology"},{"key":"key20180108021211_b4-mmr-12-04-5594","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bbrc.2007.06.155","article-title":"Endostar, a novel recombinant human endostatin, exerts antiangiogenic effect via blocking VEGF-induced tyrosine phosphorylation of KDR\/Flk-1 of endothelial cells","volume":"361","author":"Ling","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180108021211_b5-mmr-12-04-5594","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/jnci\/djj252","article-title":"Endostatin: are we waiting for Godot?","volume":"98","author":"Whitworth","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"key20180108021211_b6-mmr-12-04-5594","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ijbiomac.2010.01.017","article-title":"Characterization of a monoPEG20000-Endostar","volume":"46","author":"Tong","year":"2010","journal-title":"Int J Biol Macromol"},{"key":"key20180108021211_b7-mmr-12-04-5594","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2009.04.032","article-title":"Endostar, a modified endostatin inhibits non small cell lung cancer cell in vitro invasion through osteopontin-related mechanism","volume":"614","author":"Ni","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"key20180108021211_b8-mmr-12-04-5594","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.canlet.2010.12.004","article-title":"Endostar, a modifed recombinant human endostatin, exhibits synergistic effects with dexamethasone on angiogenesis and hepatoma growth","volume":"301","author":"Li","year":"2011","journal-title":"Cancer Lett"},{"key":"key20180108021211_b9-mmr-12-04-5594","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1177\/1535370214532595","article-title":"Endostar, a novel human recombinant endostatin, attenuates liver fibrosis in CCl4-induced mice","volume":"239","author":"Chen","year":"2014","journal-title":"Exp Biol Med (Maywood)"},{"key":"key20180108021211_b10-mmr-12-04-5594","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1440-1746.2010.06406.x","article-title":"N-methyl-4-isoleucine cyclosporine attenuates CCl-induced liver fibrosis in rats by interacting with cyclophilin B and D","volume":"26","author":"Wang","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"key20180108021211_b11-mmr-12-04-5594","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.3748\/wjg.14.2349","article-title":"Vascular endothelial growth factor attenuates hepatic sinusoidal capillarization in thioacetamide-induced cirrhotic rats","volume":"14","author":"Xu","year":"2008","journal-title":"World J Gastroenterol"},{"key":"key20180108021211_b12-mmr-12-04-5594","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jhep.2008.12.011","article-title":"Angiogenesis in liver disease","volume":"50","author":"Fern\u00e1ndez","year":"2009","journal-title":"J Hepatol"},{"key":"key20180108021211_b13-mmr-12-04-5594","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1478-3231.2010.02369.x","article-title":"Angiogenesis in chronic liver disease and its complications","volume":"31","author":"Coulon","year":"2011","journal-title":"Liver Int"},{"key":"key20180108021211_b14-mmr-12-04-5594","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.jhep.2010.07.004","article-title":"Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: New targets for the treatment of portal hypertension?","volume":"53","author":"Thabut","year":"2010","journal-title":"J Hepatol"},{"key":"key20180108021211_b15-mmr-12-04-5594","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/hep.22758","article-title":"Beneficial effects of sorafenib on splanchnic, intrahepatic and portocollateral circulations in portal hypertensive and cirrhotic rats","volume":"49","author":"Mejias","year":"2009","journal-title":"Hepatology"},{"key":"key20180108021211_b16-mmr-12-04-5594","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejphar.2013.02.026","article-title":"Study of the cellular mechanism of Sunitinib mediated inactivation of activated hepatic stellate cells and its implications in angiogenesis","volume":"705","author":"Majumder","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"key20180108021211_b17-mmr-12-04-5594","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/hep.24427","article-title":"Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis","volume":"54","author":"Thabut","year":"2011","journal-title":"Hepatology"},{"key":"key20180108021211_b18-mmr-12-04-5594","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nrm1911","article-title":"VEGF receptor signalling-in control of vascular function","volume":"7","author":"Olsson","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"key":"key20180108021211_b19-mmr-12-04-5594","doi-asserted-by":"crossref","first-page":"a006502","DOI":"10.1101\/cshperspect.a006502","article-title":"Signal transduction by vascular endothelial growth factor receptors","volume":"2","author":"Koch","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"key20180108021211_b20-mmr-12-04-5594","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1042\/BJ20110301","article-title":"Signal transduction by vascular endothelial growth factor receptors","volume":"437","author":"Koch","year":"2011","journal-title":"Biochem J"},{"key":"key20180108021211_b21-mmr-12-04-5594","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3389\/fonc.2013.00196","article-title":"Compartment model predicts VEGF secretion and investigates the effects of VEGF trap in tumor-bearing mice","volume":"3","author":"Finley","year":"2013","journal-title":"Front Oncol"},{"key":"key20180108021211_b22-mmr-12-04-5594","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1136\/gut.52.9.1347","article-title":"Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis","volume":"52","author":"Yoshiji","year":"2003","journal-title":"Gut"},{"key":"key20180108021211_b23-mmr-12-04-5594","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jhep.2005.04.002","article-title":"VEGF-induced angiogenesis drives collateral circulation in portal hypertension","volume":"43","author":"Moreau","year":"2005","journal-title":"J Hepatol"},{"key":"key20180108021211_b24-mmr-12-04-5594","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1365-2613.2008.00608.x","article-title":"An intravital microscopic study of the hepatic microcirculation in cirrhotic mice models: Relationship between fibrosis and angiogenesis","volume":"89","author":"Vanheule","year":"2008","journal-title":"Int J Exp Pathol"},{"key":"key20180108021211_b25-mmr-12-04-5594","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/sj.onc.1201912","article-title":"Coordinated induction of VEGF receptors in mesenchymal cell types during rat hepatic wound healing","volume":"17","author":"Ankoma-Sey","year":"1998","journal-title":"Oncogene"},{"key":"key20180108021211_b26-mmr-12-04-5594","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1478-3231.2010.02369.x","article-title":"Angiogenesis in chronic liver disease and its complications","volume":"31","author":"Coulon","year":"2011","journal-title":"Liver Int"},{"key":"key20180108021211_b27-mmr-12-04-5594","doi-asserted-by":"crossref","first-page":"xiii","DOI":"10.1016\/j.cld.2008.07.009","article-title":"Preface. Hepatic fibrosis: Pathogenesis, diagnosis and emerging therapies","volume":"12","author":"Friedman","year":"2008","journal-title":"Clin Liver Dis"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mmr.2015.4103\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T23:12:13Z","timestamp":1515366733000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2015.4103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,20]]},"references-count":27,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,7,20]]},"published-print":{"date-parts":[[2015,10]]}},"alternative-id":["10.3892\/mmr.2015.4103"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2015.4103","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,20]]}}}